Tylenol autism cases were largely dismissed at the Daubert stage. We're tracking related MDL developments closely — here's the funding landscape.
The acetaminophen autism / ADHD MDL faced a major setback when the Southern District of New York excluded plaintiffs' general causation experts under Daubert. Many cases were dismissed, and the litigation is on appeal at the Second Circuit.
Pre-settlement funding on Tylenol acetaminophen claims is generally on hold pending appellate developments. AARC monitors these cases and can provide updates as the landscape changes.
If you've already received funding on a Tylenol claim, your existing agreement remains in place — non-recourse means if the case ultimately loses, you owe nothing.
Other acetaminophen-related litigation continues in various venues. Funding decisions depend heavily on case status and venue.
If you have questions about your specific Tylenol case status or funding options, call AARC at (800) 297-3834 — we'll give you a straight answer.
For other mass tort funding (Camp Lejeune, hair relaxer, Roundup, hernia mesh, NEC, Paraquat), apply online for a same-day decision.
